TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies
Brigette Boast,Shubham Goel,Luis I González-Granado,Julie Niemela,Jennifer Stoddard,Emily S J Edwards,Sandali Seneviratne,Dominik Spensberger,Juan F Quesada-Espinosa,Luis M Allende,John McDonnell,Alexandria Haseley,Harry Lesmana,Magdalena A Walkiewicz,Emad Muhammad,Julian J Bosco,Thomas A Fleisher,Shai Cohen,Steven M Holland,Menno C van Zelm,Anselm Enders,Hye Sun Kuehn,Sergio D Rosenzweig
DOI: https://doi.org/10.1016/j.jaci.2023.05.017
Abstract:Background: TCF3 is a transcription factor contributing to early lymphocyte differentiation. Germline monoallelic dominant negative and biallelic loss-of-function (LOF) null TCF3 mutations cause a fully penetrant severe immunodeficiency. We identified 8 individuals from 7 unrelated families with monoallelic LOF TCF3 variants presenting with immunodeficiency with incomplete clinical penetrance. Objective: We sought to define TCF3 haploinsufficiency (HI) biology and its association with immunodeficiency. Methods: Patient clinical data and blood samples were analyzed. Flow cytometry, Western blot analysis, plasmablast differentiation, immunoglobulin secretion, and transcriptional activity studies were conducted on individuals carrying TCF3 variants. Mice with a heterozygous Tcf3 deletion were analyzed for lymphocyte development and phenotyping. Results: Individuals carrying monoallelic LOF TCF3 variants showed B-cell defects (eg, reduced total, class-switched memory, and/or plasmablasts) and reduced serum immunoglobulin levels; most but not all presented with recurrent but nonsevere infections. These TCF3 LOF variants were either not transcribed or translated, resulting in reduced wild-type TCF3 protein expression, strongly suggesting HI pathophysiology for the disease. Targeted RNA sequencing analysis of T-cell blasts from TCF3-null, dominant negative, or HI individuals clustered away from healthy donors, implying that 2 WT copies of TCF3 are needed to sustain a tightly regulated TCF3 gene-dosage effect. Murine TCF3 HI resulted in a reduction of circulating B cells but overall normal humoral immune responses. Conclusion: Monoallelic LOF TCF3 mutations cause a gene-dosage-dependent reduction in wild-type protein expression, B-cell defects, and a dysregulated transcriptome, resulting in immunodeficiency. Tcf3+/- mice partially recapitulate the human phenotype, underscoring the differences between TCF3 in humans and mice.